254 related articles for article (PubMed ID: 1346519)
1. An oxidized analog of alpha-human atrial natriuretic polypeptide is a selective agonist for the atrial-natriuretic-polypeptide clearance receptor which lacks a guanylate cyclase.
Koyama S; Terai T; Inoue T; Inomata K; Tamura K; Kobayashi Y; Kyogoku Y; Kobayashi M
Eur J Biochem; 1992 Feb; 203(3):425-32. PubMed ID: 1346519
[TBL] [Abstract][Full Text] [Related]
2. Atrial natriuretic peptide binding, cross-linking, and stimulation of cyclic GMP accumulation and particulate guanylate cyclase activity in cultured cells.
Leitman DC; Andresen JW; Catalano RM; Waldman SA; Tuan JJ; Murad F
J Biol Chem; 1988 Mar; 263(8):3720-8. PubMed ID: 2894373
[TBL] [Abstract][Full Text] [Related]
3. Increased cyclic guanosine monophosphate production and overexpression of atrial natriuretic peptide A-receptor mRNA in spontaneously hypertensive rats.
Tremblay J; Huot C; Willenbrock RC; Bayard F; Gossard F; Fujio N; Koch C; Kuchel O; Debinski W; Hamet P
J Clin Invest; 1993 Nov; 92(5):2499-508. PubMed ID: 7901238
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoid regulation of atrial natriuretic peptide receptors on cultured endothelial cells.
Lanier-Smith KL; Currie MG
Endocrinology; 1991 Nov; 129(5):2311-7. PubMed ID: 1657570
[TBL] [Abstract][Full Text] [Related]
5. Brain and atrial natriuretic peptides bind to common receptors in brain capillary endothelial cells.
Gelfand RA; Frank HJ; Levin E; Pedram A
Am J Physiol; 1991 Aug; 261(2 Pt 1):E183-9. PubMed ID: 1678581
[TBL] [Abstract][Full Text] [Related]
6. Modulation by NaCl of atrial natriuretic peptide receptor levels and cyclic GMP responsiveness to atrial natriuretic peptide of cultured vascular endothelial cells.
Katafuchi T; Mizuno T; Hagiwara H; Itakura M; Ito T; Hirose S
J Biol Chem; 1992 Apr; 267(11):7624-9. PubMed ID: 1348507
[TBL] [Abstract][Full Text] [Related]
7. [Structure and function of the receptor for human atrial natriuretic peptide in cultured human skin fibroblasts].
Ohashi M; Hashiguchi T; Takayanagi R; Haji M; Nawata H
Fukuoka Igaku Zasshi; 1990 Oct; 81(10):331-6. PubMed ID: 2175731
[TBL] [Abstract][Full Text] [Related]
8. Cyclic GMP down-regulates atrial natriuretic peptide receptors on cultured vascular endothelial cells.
Kato J; Lanier-Smith KL; Currie MG
J Biol Chem; 1991 Aug; 266(22):14681-5. PubMed ID: 1650366
[TBL] [Abstract][Full Text] [Related]
9. HeLa cells contain the atrial natriuretic peptide receptor with guanylate cyclase activity.
Watt VM; Yip CC
Biochem Biophys Res Commun; 1989 Oct; 164(2):671-7. PubMed ID: 2573350
[TBL] [Abstract][Full Text] [Related]
10. A linear analog of atrial natriuretic peptide (ANP) discriminates guanylate cyclase-coupled ANP receptors from non-coupled receptors.
Olins GM; Patton DR; Bovy PR; Mehta PP
J Biol Chem; 1988 Aug; 263(22):10989-93. PubMed ID: 2899082
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of atrial natriuretic peptide-induced cyclic GMP accumulation in the bovine endothelial cells with anti-atrial natriuretic peptide receptor antiserum.
Ishido M; Fujita T; Shimonaka M; Saheki T; Ohuchi S; Kume T; Ishigaki I; Hirose S
J Biol Chem; 1989 Jan; 264(1):641-5. PubMed ID: 2562841
[TBL] [Abstract][Full Text] [Related]
12. Atrial natriuretic peptide-C receptor-induced attenuation of adenylyl cyclase signaling activates phosphatidylinositol turnover in A10 vascular smooth muscle cells.
Mouawad R; Li Y; Anand-Srivastava MB
Mol Pharmacol; 2004 Apr; 65(4):917-24. PubMed ID: 15044621
[TBL] [Abstract][Full Text] [Related]
13. Characterization of atrial natriuretic peptide receptors in brain microvessel endothelial cells.
Whitson PA; Huls MH; Sams CF
J Cell Physiol; 1991 Jan; 146(1):43-51. PubMed ID: 1846636
[TBL] [Abstract][Full Text] [Related]
14. Characterization and regulation of atrial natriuretic peptide (ANP)-R1 receptors in the human neuroblastoma cell line NB-OK-1.
Delporte C; Poloczek P; Gossen D; Tastenoy M; Winand J; Christophe J
Eur J Pharmacol; 1991 May; 207(1):81-8. PubMed ID: 1680722
[TBL] [Abstract][Full Text] [Related]
15. Atrial natriuretic peptide, oxytocin, and vasopressin increase guanosine 3',5'-monophosphate in LLC-PK1 kidney epithelial cells.
Leitman DC; Agnost VL; Catalano RM; Schröder H; Waldman SA; Bennett BM; Tuan JJ; Murad F
Endocrinology; 1988 Apr; 122(4):1478-85. PubMed ID: 2894298
[TBL] [Abstract][Full Text] [Related]
16. A ring-reversed analog of atrial natriuretic peptide retains receptor binding, guanylate cyclase stimulation.
von Geldern TW; Budzik GP; Dillon TP
Biochem Biophys Res Commun; 1992 Jun; 185(2):734-9. PubMed ID: 1319147
[TBL] [Abstract][Full Text] [Related]
17. Brain natriuretic peptide interacts with atrial natriuretic peptide receptor in cultured rat vascular smooth muscle cells.
Hirata Y; Shichiri M; Emori T; Marumo F; Kangawa K; Matsuo H
FEBS Lett; 1988 Oct; 238(2):415-8. PubMed ID: 2844607
[TBL] [Abstract][Full Text] [Related]
18. Comparison of binding and cyclic GMP accumulation by atrial natriuretic peptides in endothelial cells.
Leitman DC; Murad F
Biochim Biophys Acta; 1986 Jan; 885(1):74-9. PubMed ID: 2867788
[TBL] [Abstract][Full Text] [Related]
19. Identification of structural requirements for analogues of atrial natriuretic peptide (ANP) to discriminate between ANP receptor subtypes.
Bovy PR; O'Neal JM; Olins GM; Patton DR
J Med Chem; 1989 Apr; 32(4):869-74. PubMed ID: 2564895
[TBL] [Abstract][Full Text] [Related]
20. HS-142-1, a novel nonpeptide atrial natriuretic peptide (ANP) antagonist, blocks ANP-induced renal responses through a specific interaction with guanylyl cyclase-linked receptors.
Morishita Y; Sano T; Kase H; Yamada K; Inagami T; Matsuda Y
Eur J Pharmacol; 1992 Mar; 225(3):203-7. PubMed ID: 1355444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
